Altered fibrin clot structure/function in patients with cryptogenic ischemic stroke

Stroke

Volumn 40, Issue 4, 2009, Pages 1499-1501

  Undas, Anetta ^a   Podolec, Piotr ^a   Zawilska, Krystyna ^b   Pieculewicz, Monika ^a,d   Jedliński, Ireneusz ^c   Stgpień, Ewa ^a,d   Konarska Kuszewska, Ewa ^e   Wȩglarz, Przemysław ^e   Duszyńska, Małgorzata ^c   Hanschke, Ewelina ^b   Przewłocki, Tadeusz ^a   Tracz, Wiesława ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c J Stru Hospital   (Poland)

^d Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

^e MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Fibrin clot; Fibrinolysis; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; D DIMER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIN; FIBRINOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; FIBRIN CLOT; FIBRINOLYSIS; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PATENT FORAMEN OVALE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN POLYMERIZATION; PROTEIN STRUCTURE; SCANNING ELECTRON MICROSCOPY; SMOKING HABIT; TURBIDIMETRY; BLOOD; BLOOD CLOTTING; BRAIN ISCHEMIA; METABOLISM; MIDDLE AGED; PERMEABILITY; PHOTOMETRY; PHYSIOLOGY; STROKE;

ADULT; BLOOD COAGULATION; BRAIN ISCHEMIA; FEMALE; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; FORAMEN OVALE, PATENT; HUMANS; MALE; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PERMEABILITY; STROKE;

EID: 65249140472     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.532812     Document Type: Article

References (12)

1. Guercini F, Acciarresi M, Agnelli G, Paciaroni M. Cryptogenic stroke: time to determine aetiology. J Thromb Haemost. 2008;6:549-554.
2. Hara H, Virmani R, Ladich E, Mackey-Bojack S, Titus J, Reisman M, Gray W, Nakamura M, Mooney M, Poulose A, Schwartz GL. Patent foramen ovale: current pathology, pathophysiology, and clinical status. J Am Coll Cardiol. 2005;46:1768-1776.
3. Scott EM, Ariens RAS, Grant PJ. Genetic and environmental determinants of fibrin structure and function. Relevance to clinical disease. Arterioscler Thromb Vasc Biol. 2004;24:1558-1566.
4. Undas A, Celinska-Lowenhoff M, Lowenhoff T, Szczeklik A. Statins, feno-fibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease. J Thromb Haemost. 2006;4:1029-1036.
5. Undas A, Szuldrzynski K, Stepien E, Zalewski J, Godlewski J, Tracz W, Pasowicz M, Zmudka K. Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress. Atherosclerosis. 2007; 196:551-558.
6. Undas A, Brozek J, Jankowski M, Siudak Z, Szczeklik A, Jakubowski H. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects. Arterioscler Thromb Vasc Biol. 2006;26:1397-1404.
7. Mills JD, Ariëns RA, Mansfield MW, Grant PJ. Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease. Circulation. 2002;106:1938-1942.
8. Blombäck B, Carlsson K, Hessel B, Liljeborg A, Procyk R, Aslund N. Native fibrin gel networks observed by 3D microscopy, permeation and turbidity. Biochim Biophys Acta. 1989;997:96-110.
9. Williams S, Fatah K, Ivert T, Blomback M. The effect of acetyl salicylic acid on fibrin gel lysis by tissue plasminogen activator. Blood Coagul Fibrinolysis. 1995;6:718-725.
10. Collet J-P, Mishal Z, Lesty C, Mirshahi M, Peyne J, Baumelou A, Bensman A, Soria J, Soria C. Abnormal fibrin clot architecture in nephritic patients is related to hypofibrinolysis: influence of plasma biochemical modifications. Thromb Haemost. 1999;82:1482-1489.
11. Bedard E, Rodes-Cabau J, Houde C, Mackey A, Rivest D, Cloutier S, Noel M, Marre A, Cote JM, Chetaille P, Delisle G, Leblanc MH, Bertrand OF. Enhanced thrombogenesis but not platelet activation is associated with transcatheter closure of patent foramen ovale in patients with cryptogenic stroke. Stroke. 2007;38:100-104.
12. Undas A, Stepien E, Tracz W, Szczeklik A. Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis. J Thromb Haemost. 2006;4:973-975.